SCOPUS BIOPHARMA
Scopus BioPharma Inc. is a biopharmaceutical company developing transformational therapeutics capitalizing on groundbreaking scientific and medical discoveries from leading research and academic institutions. The company's lead drug candidate is a novel, targeted immuno-oncology gene therapy for the treatment of multiple cancers. The company is also developing additional new chemical entities to treat other serious diseases with significant unmet medical needs, including systemic sclerosis.
SCOPUS BIOPHARMA
Social Links:
Industry:
Biopharma Biotechnology Cannabis Medical
Founded:
2018-04-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.scopusbiopharma.com
Total Employee:
1+
Status:
Active
Total Funding:
9 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager WordPress Google Universal Analytics Font Awesome
Similar Organizations
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-06-30 | Olimmune | Olimmune acquired by Scopus BioPharma | N/A |
Official Site Inspections
http://www.scopusbiopharma.com
- Host name: 104.21.34.40
- IP address: 104.21.34.40
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Scopus BioPharma"
Company Information - Scopus BioPharma
We are a biopharmaceutical company developing transformational therapeutics targeting serious diseases with significant unmet medical needs. Our mission is to improve patient outcomes …See details»
Contact - Scopus BioPharma
Corporate Headquarters 420 Lexington Avenue New York, New York 10170See details»
Scopus BioPharma - Crunchbase Company Profile & Funding
Scopus BioPharma Inc. is a biopharmaceutical company developing transformational therapeutics capitalizing on groundbreaking scientific and medical discoveries from leading research and …See details»
Scopus BioPharma Inc. (SCPS) Company Profile & Overview
Nov 15, 2024 Company profile for Scopus BioPharma Inc. (SCPS) with a description, list of executives, contact details and other key facts.See details»
Scopus Biopharma - Overview, News & Similar companies
Oct 18, 2022 Who is Scopus BioPharma. Scopus BioPharma Inc., both directly and through subsidiaries, is a clinical-stage biopharmaceutical company developing transformational …See details»
Scopus BioPharma Company Profile - Office Locations ... - Craft
Oct 29, 2024 Scopus BioPharma has 2 employees at their 1 location. See insights on Scopus BioPharma including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Scopus Biopharma - VentureRadar
Website: https://scopusbiopharma.com/ Develops clinical-stage biopharmaceuticals for serious diseases with unmet medical needs, focusing on novel immuno-oncology RNA ...See details»
Press Releases - Scopus BioPharma
Nov 22, 2021 Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — Announces Key Scientific Data to be Presented at the 37th Annual Meeting and Exposition of the Society for …See details»
Scopus BioPharma - PitchBook
Scopus BioPharma General Information Description. Scopus BioPharma Inc a biotechnology company focused on developing therapeutics targeting the endocannabinoid system.See details»
Scopus Biopharma Inc - Company Profile and News
Company profile page for Scopus Biopharma Inc including stock price, company news, executives, board members, and contact informationSee details»
Scopus BioPharma Inc. (SCPS) - Yahoo Finance Canada
Find the latest Scopus BioPharma Inc. (SCPS) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
SCPS: Scopus Biopharma Inc Stock Price Quote - OTC US
Nov 23, 2024 Stock analysis for Scopus Biopharma Inc (SCPS:OTC US) including stock price, stock chart, company news, key statistics, fundamentals and company profile.See details»
Scopus Biopharma Completes Recapitalization Designed To …
Oct 18, 2022 Warrants to Purchase Approximately 21 Million Scopus Shares Eliminated Scopus BioPharma’s Pure Play Immuno-Oncology Subsidiary, Duet BioTherapeutics, Independently …See details»
Scopus BioPharma - Corporate Presentation (09.14.20) FINAL
í ò d o v } u d } o:log w\sh frqwuro 7xpruv duh jrqh < } Ç o Á l ] d x o x e µ d x î ì ì ñ vSee details»
Scopus BioPharma Announces $9.75 Million Private Placement
NEW YORK, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (Nasdaq: “SCPS”), a clinical-stage biopharmaceutical company developing...See details»
Scopus BioPharma Announces New Date for 2021 Annual Meeting …
NEW YORK, May 31, 2021 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (Nasdaq: “SCPS”) today announced that the board of directors has rescheduled the company’s 2021 Annual …See details»
Scopus BioPharma Announces Biotechnology Industry Leader …
Scopus BioPharma Announces Biotechnology Industry Leader Rejoins Board of Directors (05.05.22) FINALSee details»
Scopus BioPharma Announces FDA Approval of IND Application
May 24, 2021 CpG-STAT3siRNA is a Distinctive RNA Therapy and Immunotherapy Developed at City of Hope A Phase 1 Clinical Trial Will be Initiated at City of Hope NEW...See details»
Scopus BioPharma - Corporation Presentation (01.18.21) DRAFT
í ò d o v } u d } o:log w\sh frqwuro 7xpruv duh jrqh %odfn olqhv vkrz &s* dqg 67$7 dorqh gr qrw lqklelw wxpru jurzwk hiihfwlyho\See details»